• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of color additive regulatory package reviews received via FDA's electronic Compliance Management System (CMS) that meet Office of Compliance (OC) timeframes as specified in CMS in the quarter

Dictionary: The law requires that certain color additives be tested and certified by FDA before they can be used in foods, drugs, cosmetics, medical devices, and pet foods. The Color Certification Program tests each and every batch of these color additives, which come from more than 31 domestic and foreign manufacturers. It is estimated that there is only a two week supply of color between FDA certification laboratories and manufacturers of finished products for purchase by U.S. consumers. FDA continues to strive for accurate and timely testing to ensure that this flow of safe certified color additives is not interrupted.

Information is current as of June 30, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetPercentage
Oct-Dec 2013N/A100
Jan-Mar 2014N/A100
Apr-Jun 2014N/A100
Jul-Sept 2014N/ATBD

FY 2014 YTD: 100%

Footnotes

  • CFSAN's Office of Compliance began tracking this measure in FDA-TRACK in FY13 Q3.

Number of color additive regulatory package reviews received via CMS that meet OC timeframes in the quarter

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct-Dec 2013N/A11
Jan-Mar 2014N/A14
Apr-Jun 2014N/A12
Jul-Sept 2014N/ATBD

FY 2014 YTD: 37

Total number of color additive regulatory packages reviewed within CMS in the quarter

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct-Dec 2013N/A11
Jan-Mar 2014N/A14
Apr-Jun 2014N/A12
Jul-Sept 2014N/ATBD

FY 2014 YTD: 37

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.